Who is sponsoring NCT05290753?

NCT05290753 is sponsored by Sohag University.

What drugs are being tested in NCT05290753?

Interventions in NCT05290753: Prokinetic Motility Agents as primpiram and gastreg.

What condition does NCT05290753 study?

NCT05290753 studies Prokinetic Use After Emergency Intestinal Anastomosis.

Is NCT05290753 still recruiting?

NCT05290753 is currently status unknown. Last updated 3 May 2022.

Last reviewed 2022-05-03 · How we verify

NCT05290753

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Prokinetic Use After Emergency Intestinal Anastomosis on Postoperative Clinical Outcomes

Status unknown NA Last updated 3 May 2022

What this trial tests

NA trial testing Prokinetic Motility Agents as primpiram and gastreg in Prokinetic Use After Emergency Intestinal Anastomosis in 15 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
1 June 2022

1 July 2022

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	15
Start date	1 January 2022
Primary completion	1 June 2022
Estimated completion	1 July 2022
Sites	1 location across Egypt

Drugs / interventions tested

Prokinetic Motility Agents as primpiram and gastreg — full drug profile →

Conditions studied

Prokinetic Use After Emergency Intestinal Anastomosis — all drugs for Prokinetic Use After Emergency Intestinal Anastomosis →

Sponsor

Sohag University

Who can join

12 and older, any sex, with Prokinetic Use After Emergency Intestinal Anastomosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prokinetic drugs used to accelerate healing of intestinal anastomosis of urgent cases which not prepared preoperative by increase intestinal motility and gastric emptying and decrease postoperative adhesions They are many types of prokinetics as cholinergic agonists, dopamine antagonist, serotonergic agonists and macrolides Agents of prokinetics administered immediately post operation and at the time of hospitalization

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05290753 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 3 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05290753.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing